Enliven Therapeutics ELVN Operating Lease Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities
Operating Lease Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept elvn:OperatingLeaseRightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilities.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's operating lease right of use assets obtained in exchange for operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's operating lease right of use assets obtained in exchange for operating lease liabilities?
- Enliven Therapeutics (ELVN) reported operating lease right of use assets obtained in exchange for operating lease liabilities of $0 in Q1 2026.
- How has Enliven Therapeutics's operating lease right of use assets obtained in exchange for operating lease liabilities changed year-over-year?
- Enliven Therapeutics's operating lease right of use assets obtained in exchange for operating lease liabilities decreased by 100.0% year-over-year, from $736K to $0.
- What does operating lease right of use assets obtained in exchange for operating lease liabilities mean?
- This metric represents the non-cash value of right-of-use assets recognized by the company when entering into new operating lease agreements. It reflects the initial capitalization of lease obligations on the balance sheet, indicating the scale of new long-term facility or equipment commitments. Monitoring this figure helps investors understand the company's expansion of its physical footprint and future fixed-cost obligations without immediate cash outflows.